KBMED is pleased to announce that its Combined Epidural & Spinal Kit (CSE Kit) has officially received registration approval from the Directorate General of Drug Administration (DGDA) of Bangladesh. This achievement follows the successful registration of KBMED's Epidural Kit, marking another important milestone in the company's growing Anesthesia & Pain Management portfolio. Expanding Pain Management Solutions in Bangladesh As one of South Asia's emerging healthcare markets,

Recently, KBMED’s NRFit product package has entered sample evaluation and testing with partners in Northern Ireland. Following successful assessments, large-volume procurement is expected to begin in the near future, reflecting increasing market readiness for next-generation non-interconnectable connector systems. ISO 80369: Driving Safer Medical Connections The ISO 80369 series was developed by the International Organization for Standardization to address one of the most cri

I rvine, California — KB Medical Group (KBMED) is proud to announce the successful shipment and delivery of a full 40-foot high-quality...

June 2025 – California, USA / Dhaka, Bangladesh — KBMED, a global leader in high-performance medical technology, proudly announces that...